drugset / Trial / NCT03713216

Comparison of the Efficacy and Safety of NALDEBAIN With Conventional Treatment After Laparoscopic Cholecystectomy

NCT03713216

Phase 4 Completed 44 enrolled Cathay General Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

To determine the effect and safety of NALDEBAIN versus Morphine as needed in patients after laparoscopic cholecystectomy.

Timeline

Start
2018-07-01
Primary completion
2019-10-01
Completion
2020-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dinalbuphine sebacate Small molecule 150 mg Intramuscular
Comparator Morphine Other / unclassified

Indications

No indication recorded.